Lantern Pharma Inc.
NASDAQ:LTRN
Cash Flow Statement
Cash Flow Statement
Lantern Pharma Inc.
| Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||
| Net Income |
(2)
|
(3)
|
(4)
|
(6)
|
(8)
|
(9)
|
(12)
|
(12)
|
(14)
|
(16)
|
(14)
|
(14)
|
(14)
|
(14)
|
(15)
|
(16)
|
(18)
|
(18)
|
(19)
|
(21)
|
(20)
|
(19)
|
(19)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
1
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
|
| Change in Working Capital |
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
1
|
1
|
1
|
(0)
|
(1)
|
(1)
|
(2)
|
0
|
1
|
3
|
2
|
2
|
2
|
0
|
1
|
1
|
|
| Cash from Operating Activities |
(2)
N/A
|
(2)
-2%
|
(5)
-118%
|
(6)
-6%
|
(7)
-25%
|
(8)
-17%
|
(10)
-21%
|
(11)
-5%
|
(12)
-11%
|
(13)
-8%
|
(12)
+5%
|
(13)
-5%
|
(13)
-3%
|
(14)
-7%
|
(14)
+3%
|
(14)
-5%
|
(14)
+5%
|
(15)
-12%
|
(17)
-13%
|
(18)
-3%
|
(19)
-7%
|
(18)
+7%
|
(17)
+6%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||
| Capital Expenditures |
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
(18)
|
(19)
|
(20)
|
(19)
|
(2)
|
(1)
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
3
|
7
|
11
|
16
|
|
| Cash from Investing Activities |
0
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
0
N/A
|
(18)
N/A
|
(19)
-6%
|
(20)
-1%
|
(19)
+1%
|
(2)
+92%
|
(1)
+59%
|
0
N/A
|
(1)
N/A
|
(1)
+7%
|
(1)
+34%
|
(1)
-58%
|
(1)
+43%
|
(0)
+49%
|
0
N/A
|
3
+1 752%
|
7
+113%
|
11
+53%
|
16
+48%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||
| Net Issuance of Common Stock |
1
|
27
|
27
|
26
|
95
|
69
|
69
|
68
|
(3)
|
(3)
|
(3)
|
(2)
|
0
|
0
|
0
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
(3)
|
(3)
|
(3)
|
(8)
|
(5)
|
(5)
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
1
N/A
|
25
+2 005%
|
25
0%
|
24
-4%
|
88
+271%
|
64
-27%
|
64
+0%
|
63
-1%
|
(3)
N/A
|
(3)
N/A
|
(3)
N/A
|
(2)
+29%
|
0
N/A
|
0
N/A
|
0
N/A
|
(1)
N/A
|
(0)
+11%
|
(0)
N/A
|
(0)
+3%
|
0
N/A
|
0
-82%
|
0
N/A
|
1
N/A
|
|
| Change in Cash | ||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Change in Cash |
(1)
N/A
|
22
N/A
|
19
-13%
|
18
-7%
|
81
+349%
|
38
-53%
|
35
-7%
|
33
-4%
|
(34)
N/A
|
(17)
+49%
|
(16)
+9%
|
(15)
+7%
|
(14)
+4%
|
(15)
-5%
|
(14)
+5%
|
(16)
-11%
|
(15)
+7%
|
(16)
-9%
|
(17)
-9%
|
(14)
+17%
|
(12)
+17%
|
(7)
+42%
|
0
N/A
|
|
| Free Cash Flow | ||||||||||||||||||||||||
| Free Cash Flow |
(2)
N/A
|
(2)
-3%
|
(5)
-117%
|
(6)
-6%
|
(7)
-25%
|
(8)
-18%
|
(10)
-22%
|
(11)
-5%
|
(12)
-11%
|
(13)
-9%
|
(12)
+5%
|
(13)
-5%
|
(13)
-3%
|
(14)
-6%
|
(14)
+3%
|
(14)
-5%
|
(14)
+5%
|
(15)
-12%
|
(17)
-13%
|
(18)
-3%
|
(19)
-7%
|
(18)
+7%
|
(17)
+6%
|
|